LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial
Golan, Talia, Geva, Ravit, Richards, Donald, Madhusudan, Srinivasan, Lin, Boris Kin, Wang, Haofei Tiffany, Walgren, Richard A., Stemmer, Salomon M.·2018·Journal of Cachexia, Sarcopenia and Muscle
Cited by (113)
Items 101–113 of 113
- Background and Management of Muscular AtrophyJulianna Cseri · 2020 · IntechOpen eBooks
- Anabolic and anticatabolic agents in kidney disease and kidney failureJanet M. Chiang, Kirsten L. Johansen · 2021 · Elsevier eBooks
- Peptide Tool-Driven Functional Elucidation of Biomolecules Related to Endocrine System and MetabolismKentaro Takayama · 2022 · Chemical and Pharmaceutical Bulletin
- Cancer CachexiaAssaad Antoine Eid, Rachel Njeim, Fadlo Raja Khuri, David K. Thomas · 2022 · Holland‐Frei Cancer Medicine
- Continue to treat sarcopenia with exercise and diet while potential pharmacotherapies are under investigationAisling McGuigan · 2025 · Drugs & Therapy Perspectives
- The Molecular Mechanisms and Treatment of Cancer-Related CachexiaYongfei YOU, Yong WANG, Guohua Zhang, Yong Li · 2025 · Journal of Nutritional Science and Vitaminology
- Systematic review of randomised controlled trials and network meta-analysis in the prevention and treatment of cachexia in people with pancreatic cancer (Preprint)Kurinchi Selvan Gurusamy, Danielle Amanda Roberts, Sarah Prideaux, Amandeep Kaur Gill, Prabha Doraisami, Ankita C. Redla, Emilia Magdalena Postaleniec, Amy Still, Giselle Ngan, Jashan Selvakumar et al. · 2026
- Pretherapeutic radiological sarcopenia in pancreatic ductal adenocarcinoma: a narrative reviewMyriam Ayari, Sarah Ben Azouz, A. Chehaider, Taieb Jomni · 2026 · Future Science OA
- Clinical and Proteomic Biomarkers of Trifluridine/Tipiracil in Fluoropyrimidine-Refractory Advanced Pancreatic Adenocarcinoma: A Single-Arm Phase II TrialChi‐Leung Chiang, Sik-Kwan Chan, Ann Shing Francis Lee, Ka Ming Eric Lam, Chun Yin Edwin Wong, Chun Wan Dominic Chan, Kristy Kwan‐Shuen Chan, Stephen Li, Jason W.H. Wong, Keith Wan-Hang Chiu et al. · 2026 · JCO Precision Oncology
- BindingDB Entry 50010478: Discovery of a follistatin-derived myostatin inhibitory peptide.BindingDB · 2021 · UC San Diego
- BindingDB Entry 50018426: Inactivation of myostatin by photooxygenation using functionalized d-peptides.BindingDB · 2024 · UC San Diego
- BindingDB Entry 50015290: Development of Myostatin Inhibitory d-Peptides to Enhance the Potency, Increasing Skeletal Muscle Mass in Mice.BindingDB · 2023 · UC San Diego
- BindingDB Entry 50009097: Chain-Shortened Myostatin Inhibitory Peptides Improve Grip Strength in Mice.BindingDB · 2021 · UC San Diego